Page last updated: 2024-08-21

quinazolines and Aseptic Necrosis of Bone

quinazolines has been researched along with Aseptic Necrosis of Bone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broniscer, A; Gajjar, A; Kaste, SC; Kaufman, RA	1
Heinemann, V; Rack, B; Salat, C; Schindlbeck, C; Sommer, H; Walther, J	1

Reviews

1 review(s) available for quinazolines and Aseptic Necrosis of Bone

Article	Year
[Metastatic breast cancer--new methods of treatment]. MMW Fortschritte der Medizin, 2008, Jan-17, Volume: 150, Issue:1-2 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Female; Histocytochemistry; Humans; Lapatinib; Neoplasm Metastasis; Osteonecrosis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Risk Factors; Signal Transduction; Time Factors; Trastuzumab	2008

Article

Year

[Metastatic breast cancer--new methods of treatment].

MMW Fortschritte der Medizin, 2008, Jan-17, Volume: 150, Issue:1-2

Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Female; Histocytochemistry; Humans; Lapatinib; Neoplasm Metastasis; Osteonecrosis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Risk Factors; Signal Transduction; Time Factors; Trastuzumab

2008

Trials

1 trial(s) available for quinazolines and Aseptic Necrosis of Bone

Article	Year
Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors. Pediatric blood & cancer, 2013, Volume: 60, Issue:9 Topics: Adolescent; Adult; Angiogenesis Inhibitors; Brain Stem Neoplasms; Child; Child, Preschool; Dasatinib; Female; Follow-Up Studies; Glioma; Humans; Infant; Knee Joint; Magnetic Resonance Imaging; Male; Osteonecrosis; Piperidines; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Radiography; Thiazoles; Vascular Endothelial Growth Factor Receptor-2	2013

Article

Year

Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors.

Pediatric blood & cancer, 2013, Volume: 60, Issue:9

Topics: Adolescent; Adult; Angiogenesis Inhibitors; Brain Stem Neoplasms; Child; Child, Preschool; Dasatinib; Female; Follow-Up Studies; Glioma; Humans; Infant; Knee Joint; Magnetic Resonance Imaging; Male; Osteonecrosis; Piperidines; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Radiography; Thiazoles; Vascular Endothelial Growth Factor Receptor-2

2013